Dissociation of tumor cells followed by FACS analysis showed a significant increase of macrophages (CD45+ Gr-1− F4/80+ CD11b+) in AR-silenced YUMM1.7 melanomas, consistent with what we observed with human cells in immune-compromised mice (Fig. 10 G). Here, PTPRC is linked to melanoma.